Articles From: Medgenics Announces Director Enters into Stock Trading Plan and Change of Adviser to Media Advisory - Behind the Curtain: An exclusive interview with the Scotiabank Giller Prize jury


2013/12/24
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of Biopump TM , a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that, on 23 December 2013, Dr.
Sign-up for Medgenics Announces Director Enters into Stock Trading Plan and Change of Adviser investment picks
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) , developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces the appointment of a new executive leadership team with the goal of accelerating the development of the company’s gene therapy platform and maximizing the value of the company’s technology assets.
Sign-up for Medgenics Announces New Executive Leadership Team investment picks
Medgenics, Inc. (NYSE MKT:MDGN and AIM:MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces the appointment of Wilbur H.
Sign-up for Medgenics Appoints Biopharmaceutical Industry Veteran Bill Gantz to its Board of Directors investment picks
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of Biopump (TM) a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that on January 2, 2014, the Company granted options to subscribe for 15,000 shares of the Company’s common stock, par value US$0.0001 (“Common Shares”) (“Options”) and made a restricted share award of 7,000 Common Shares (“Restricted Shares”) to each of Sol Barer, Isaac Blech, Alastair Clemow, Wilbur “Bill” Gantz, Joseph Grano, Jr., Joel Kanter, Stephen McMurray, and Andrew Pearlman, all non-executive directors of the Company, as part of their remuneration for the year.
Sign-up for Medgenics Issues Stock Options and Restricted Shares to Non-Executive Directors investment picks
2014/2/20
WAYNE, Pa.
Sign-up for Medgenics Reports 2013 Financial Results investment picks
2013/12/3
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of Biopump (TM) a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that on December 2, 2013, was informed by Dr.
Sign-up for Medgenics Reports Open Market Purchase of Common Stock by Chairman of the Board investment picks
2013/12/16
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of Biopump (TM) a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that on December 13, 2013, the Company was informed by Dr.
Sign-up for Medgenics Reports Open Market Purchase of Common Stock by Chairman of the Board investment picks
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of Biopump (TM) a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that the Company was informed today by Dr.
Sign-up for Medgenics Reports Open Market Purchase of Common Stock by Director investment picks
Medgenics, Inc. (NYSE MKT:MDGN and AIM:MEDU, MEDG) , developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that new, positive data on the Company’s second-generation viral vectors were highlighted in a poster presentation at the European Society of Gene and Cell Therapy Congress.
Sign-up for Medgenics Reports Positive Data with Second-Generation Viral Vectors at European Society of Gene and Cell Therapy Congress investment picks
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of Biopump TM , a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that on December 2, 2013 and December 3, 2013, the Company was informed by Dr.
Sign-up for Medgenics Reports Sale of Common Stock by Director investment picks
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today reported financial results for the three and six months ended June 30, 2013 and the filing with the U.S. Securities and Exchange Commission (SEC) of the Company’s Quarterly Report on Form 10-Q.
Sign-up for Medgenics Reports Second Quarter Financial Results investment picks
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today reported financial results for the three and nine months ended September 30, 2013 and the filing with the U.S. Securities and Exchange Commission (SEC) of the Company’s Quarterly Report on Form 10-Q.
Sign-up for Medgenics Reports Third Quarter Financial Results investment picks
Medgenics, Inc. (NYSE MKT:MDGN and AIM:MEDU, MEDG) (the Company), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that Company management will participate in the Oppenheimer 24 th Annual Healthcare Conference taking place from December 10-11, 2013 in New York City.
Sign-up for Medgenics to Present at the Oppenheimer 24th Annual Healthcare Conference investment picks
Medgenics, Inc. (NYSEMKT:MDGN)(AIM:MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that a poster highlighting the Company’s second-generation EPODURE Biopump™ will be presented at the European Society of Gene and Cell Therapy Congress, taking place in Madrid October 25-28.
Sign-up for Medgenics to Present Poster at European Society of Gene and Cell Therapy Congress to Highlight Results from Second-Generation Viral Vector investment picks
2013/10/3
Media Advisory - A special event to announce the 2013 Scotiabank Giller Prize shortlist at the Soho House in Toronto, hosted by Jian Ghomeshi.
Sign-up for Media Advisory - A special event to announce the 2013 Scotiabank Giller Prize shortlist at the Soho House in Toronto, hosted by Jian Ghomeshi. investment picks
2014/1/31
Media Advisory - Aimia to present 2013 fourth quarter results Canada NewsWire Date:    Thursday, February 27, 2014     Time:    8:00 - 9:00 a.m. ET     By telephone:   1-888-231-8191 or 647-427-7450   Please allow 10 minutes to be connected to the conference call.
Sign-up for Media Advisory - Aimia to present 2013 fourth quarter results investment picks
Media Advisory - Aimia to present 2013 Third Quarter Results Canada NewsWire Date:    Thursday, November 14, 2013     Time:    8:00 - 9:00 a.m. ET     By telephone:   1-888-231-8191 or 647-427-7450   Please allow 10 minutes to be connected to the conference call.
Sign-up for Media Advisory - Aimia to present 2013 Third Quarter Results investment picks
2013/10/3
Media Advisory - Air Canada Executive Vice President & Chief Financial Officer Michael Rousseau, to Present at RBC - 2013 Canadian Airline & Aerospace Investor Day Canada NewsWire What: Air Canada presentation to investors at the RBC - 2013 Canadian Airline &  Aerospace Investor Day   When: Monday, October 7, 2013 at 11:30 a.m. ET This event will not be webcast.
Sign-up for Media Advisory - Air Canada Executive Vice President & Chief Financial Officer Michael Rousseau, to Present at RBC - 2013 Canadian Airline & Aerospace Investor Day investment picks
2014/2/18
Media Advisory - Air Canada Executive Vice President and Chief Financial Officer, Michael Rousseau to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference Canada NewsWire MONTREAL , Feb.
Sign-up for Media Advisory - Air Canada Executive Vice President and Chief Financial Officer, Michael Rousseau to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference investment picks
Media Advisory - Air Canada Executive Vice President and Chief Financial Officer, Michael Rousseau, to Present at CIBC 12th Annual Eastern Institutional Investor Conference Canada NewsWire What: Air Canada presentation to investors at CIBC 12 th Annual Eastern Institutional Investor Conference   When: Wednesday September 18, 2013 at 9:10 a.m. ET   Where: Le Centre Sheraton Hotel, Montreal   Webcast: Listen-in audio webcast of the presentation will be available at: https://webcasts.welcome2theshow.com/cibc2013invest Please ensure sufficient time to register prior to the live audio webcast.
Sign-up for Media Advisory - Air Canada Executive Vice President and Chief Financial Officer, Michael Rousseau, to Present at CIBC 12th Annual Eastern Institutional Investor Conference investment picks
Media Advisory - Air Canada Executive Vice President and Chief Financial Officer, Michael Rousseau, to present at the AltaCorp Capital and ATB Corporate Financial Services Institutional Investor Conference Canada NewsWire What:   Air Canada to present at the AltaCorp Capital and ATB Corporate Financial Services Institutional Investor Conference When:   Thursday, January 16, 2014 at 9:15 a.m. ET Where:   Shangri-la Hotel in Toronto Webcast:  Listen-in audio webcast of this conference will be available at: http://www.meetview.com/altacorp20140116/ Please ensure sufficient time to register prior to the live audio webcast.
Sign-up for Media Advisory - Air Canada Executive Vice President and Chief Financial Officer, Michael Rousseau, to present at the AltaCorp Capital and ATB Corporate Financial Services Institutional Investor Conference investment picks
2013/11/14
Media Advisory - Air Canada President and Chief Executive Officer, Calin Rovinescu, to Present at Scotiabank Transportation and Aerospace Conference 2013 Canada NewsWire MONTREAL , Nov.
Sign-up for Media Advisory - Air Canada President and Chief Executive Officer, Calin Rovinescu, to Present at Scotiabank Transportation and Aerospace Conference 2013 investment picks
Media Advisory - Air Canada to Present 2013 Third Quarter Results Canada NewsWire ANALYST CONFERENCE CALL / AUDIO WEBCAST Date:     Friday, November 8, 2013     Time:     9:00 a.m. ET     By telephone:   1-866-226-1798 toll free or (416) 340-2219 for the Toronto area.
Sign-up for Media Advisory - Air Canada to Present 2013 Third Quarter Results investment picks
2013/11/4
Media advisory - Atrium Innovations to Hold 2013 Third Quarter Financial Results Conference Call and Webcast on November 12, 2013 Canada NewsWire Date:   Tuesday, November 12, 2013   Time:   8:00 a.m. Eastern time   By Telephone:   514-807-9895 (Montreal Area)   888-231-8191 (Toll Free)   647-427-7450 (Toronto Area and Overseas)   Live Webcast:   http://www.atrium-innovations.com/en/atrium-innovations-announces-2013-third-quarter-financial-results (will remain available for a period of 30 days) About Atrium Innovations Atrium Innovations Inc .
Sign-up for Media advisory - Atrium Innovations to Hold 2013 Third Quarter Financial Results Conference Call and Webcast on November 12, 2013 investment picks
2013/10/15
Media Advisory - Atrium Innovations to Host Analyst/Investor Meeting in Montreal on November 20 Canada NewsWire Agenda: 12:00-2:00 p.m. Formal presentations by:        Pierre Fitzgibbon, President & CEO Don Allen, Global Supply Chain & Technical Operations Kyle Bliffert, North American Head of HCP Paul Hannema, European Head of HCP Brian Ray, North American Head of HFS, DTC and CMO Karen Ruettgers, Worldwide Head of Wobenzym ®     2:00-3:00 p.m. Informal questions session About Atrium Innovations Atrium Innovations Inc. (TSX: ATB) is a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries.
Sign-up for Media Advisory - Atrium Innovations to Host Analyst/Investor Meeting in Montreal on November 20 investment picks
Media Advisory - Atrium Innovations to Present at the Canaccord Genuity 33rd Annual Growth Conference on August 14, 2013 Canada NewsWire Date and time :   Wednesday August 14, 2013 4:00 p.m. Eastern time     Location : InterContinental Boston 510 Atlantic Avenue Boston, MA 02210 United States     Webcast :  http://www.atrium-innovations.com/en/canaccord-genuity-33rd-annual-growth-conference-presentation/ (On the Company's website) About Atrium Innovations Atrium Innovations Inc .
Sign-up for Media Advisory - Atrium Innovations to Present at the Canaccord Genuity 33rd Annual Growth Conference on August 14, 2013 investment picks
2014/3/12
Media advisory - Be there when Clara's Big Ride for Bell Let's Talk gets rolling in support of Canadian mental health Canada NewsWire TORONTO , March 12, 2014 /CNW Telbec/ - On March 14 , Clara Hughes sets out from Toronto on Clara's Big Ride for Bell Let's Talk, a 12,000 kilometre journey around Canada to grow the conversation about mental health on the road to a stigma-free Canada.
Sign-up for Media advisory - Be there when Clara's Big Ride for Bell Let's Talk gets rolling in support of Canadian mental health investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Medgenics Announces Director Enters into Stock Trading Plan and Change of Adviser to Media Advisory - Behind the Curtain: An exclusive interview with the Scotiabank Giller Prize jury
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity